Partnerships to Support Emerging Therapies and Tools
Innovation at Gillette Children's has included partnerships that have led to:
- pioneering surgical procedures and new medical devices
- clinical trials of new therapeutics
- development of artificial intelligence for improved use of clinical data
- integrating digital health technologies like virtual reality and wearable health trackers
- simulations and 3-D printing technologies for training and teaching
- new care pathways to guide clinician and family decisions
- and much more!
Since our founding, Gillette Children’s has built a history of innovation. Our culture and infrastructure are designed to nurture advancements in diagnostics, therapies and care delivery and introduce them into clinical practice around the globe.
Our Emerging Therapies Team works closely with external partners to support the development of clinical trials and implement pilot programs. The team includes members from clinical operations, payer relations, supply chain and research to facilitate streamlined implementation.
Recent Publications and Resources
Deep neural networks enable quantitative movement analysis using single-camera videos
Kidziński Ł, Yang B, Hicks JL, Rajagopal A, Delp SL, Schwartz MH. Deep neural networks enable quantitative movement analysis using single-camera videos. Nat Commun. 2020 Aug 13;11(1):4054. doi: 10.1038/s41467-020-17807-z. PMID: 32792511; PMCID: PMC7426855.
Distal Tibial Guided Growth for Anterolateral Bowing of the Tibia: Fracture May Be Prevented
Laine JC, Novotny SA, Weber EW, Georgiadis AG, Dahl MT. Distal Tibial Guided Growth for Anterolateral Bowing of the Tibia: Fracture May Be Prevented. J Bone Joint Surg Am. 2020 Dec 2;102(23):2077-2086. doi: 10.2106/JBJS.20.00657. PMID: 33093298.
Innovations in Pediatric Prosthetics
Hall, M., Wustrack, R., Cummings, D., Welling Jr., R., Kaleta, M., Koenig Jr., K., Laine, J., & Morgan, S. (2021). Innovations in pediatric prosthetics. J Pediatr Soc North Am. 2021 Feb;3(1):1-9. Available from: https://www.jposna.org/ojs/index.php/jposna/article/view/221
Mutations disrupting neuritogenesis genes confer risk for cerebral palsy
Jin SC, Lewis SA, Bakhtiari S, Zeng X, Sierant MC, Shetty S, Nordlie SM, Elie A, Corbett MA, Norton BY, van Eyk CL, Haider S, Guida BS, Magee H, Liu J, Pastore S, Vincent JB, Brunstrom-Hernandez J, Papavasileiou A, Fahey MC, Berry JG, Harper K, Zhou C, Zhang J, Li B, Zhao H, Heim J, Webber DL, Frank MSB, Xia L, Xu Y, Zhu D, Zhang B, Sheth AH, Knight JR, Castaldi C, Tikhonova IR, López-Giráldez F, Keren B, Whalen S, Buratti J, Doummar D, Cho M, Retterer K, Millan F, Wang Y, Waugh JL, Rodan L, Cohen JS, Fatemi A, Lin AE, Phillips JP, Feyma T, MacLennan SC, Vaughan S, Crompton KE, Reid SM, Reddihough DS, Shang Q, Gao C, Novak I, Badawi N, Wilson YA, McIntyre SJ, Mane SM, Wang X, Amor DJ, Zarnescu DC, Lu Q, Xing Q, Zhu C, Bilguvar K, Padilla-Lopez S, Lifton RP, Gecz J, MacLennan AH, Kruer MC. Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nat Genet. 2020 Oct;52(10):1046-1056. doi: 10.1038/s41588-020-0695-1. Epub 2020 Sep 28. Erratum in: Nat Genet. 2021 Mar;53(3):412. PMID: 32989326.